• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hyperuricemia and progression of chronic kidney disease: to treat or not to treat?

作者信息

Floege Jürgen, Johnson Richard J

机构信息

Division of Nephrology, RWTH Aachen University Hospital, Aachen, Germany.

Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

出版信息

Kidney Int. 2021 Jan;99(1):14-16. doi: 10.1016/j.kint.2020.10.022.

DOI:10.1016/j.kint.2020.10.022
PMID:33390225
Abstract
摘要

相似文献

1
Hyperuricemia and progression of chronic kidney disease: to treat or not to treat?高尿酸血症与慢性肾脏病进展：治疗还是不治疗？
Kidney Int. 2021 Jan;99(1):14-16. doi: 10.1016/j.kint.2020.10.022.
2
Effectiveness of febuxostat in patients with allopurinol-refractory hyperuricemic chronic kidney disease
.非布司他在别嘌醇难治性高尿酸血症慢性肾脏病患者中的疗效
Int J Clin Pharmacol Ther. 2018 Jul;56(7):321-327. doi: 10.5414/CP202735.
3
The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3-5.非布司他与别嘌醇对中国无症状高尿酸血症合并3 - 5期慢性肾脏病患者的降尿酸疗效及安全性比较
Clin Exp Nephrol. 2019 Mar;23(3):362-370. doi: 10.1007/s10157-018-1652-5. Epub 2018 Oct 5.
4
Comparison of renoprotective effects of febuxostat and allopurinol in hyperuricemic patients with chronic kidney disease.比较别嘌醇和非布司他在高尿酸血症慢性肾脏病患者中的护肾作用。
Int Urol Nephrol. 2019 Mar;51(3):467-473. doi: 10.1007/s11255-018-2051-2. Epub 2019 Jan 2.
5
Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients with chronic kidney disease (NU-FLASH trial for CKD).非布司他与别嘌醇治疗慢性肾脏病心脏手术患者高尿酸血症的比较（CKD的NU-FLASH试验）
J Cardiol. 2015 Oct;66(4):298-303. doi: 10.1016/j.jjcc.2014.12.017. Epub 2015 Jan 31.
6
Comparison of long-term efficacy and renal safety of febuxostat and allopurinol in patients with chronic kidney diseases
.非布司他与别嘌醇对慢性肾脏病患者的长期疗效及肾脏安全性比较
Int J Clin Pharmacol Ther. 2020 Jan;58(1):21-28. doi: 10.5414/CP203466.
7
Allopurinol Against Progression of Chronic Kidney Disease.别嘌醇与慢性肾脏病进展的关系
Iran J Kidney Dis. 2017 Jul;11(4):286-293.
8
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.非布司他与别嘌醇及安慰剂对高尿酸血症和痛风患者降低血清尿酸的作用：一项为期28周的III期随机双盲平行组试验。
Arthritis Rheum. 2008 Nov 15;59(11):1540-8. doi: 10.1002/art.24209.
9
Suggested statistical reappraisal of data from comparative study of febuxostat and allopurinol in chronic kidney disease.对非布司他与别嘌醇在慢性肾脏病中进行比较研究所得数据的建议性统计学重新评估。
Clin Rheumatol. 2014 Dec;33(12):1837. doi: 10.1007/s10067-014-2788-7. Epub 2014 Oct 3.
10
The efficacy of febuxostat and allopurinol in the treatment of gout with hyperuricemia.非布司他与别嘌醇治疗痛风伴高尿酸血症的疗效。
Pak J Pharm Sci. 2018 Jul;31(4(Special)):1623-1627.

引用本文的文献

1
Effectiveness of Allopurinol on Uric Acid and Pediatric Chronic Kidney Disease Severity in the Chronic Kidney Disease in Children Study.别嘌醇对儿童慢性肾脏病研究中尿酸及小儿慢性肾脏病严重程度的疗效
Kidney Med. 2025 May 8;7(7):101021. doi: 10.1016/j.xkme.2025.101021. eCollection 2025 Jul.
2
The correlation between dietary inflammatory index and risk of hyperuricemia in the U.S. population.膳食炎症指数与美国人群高尿酸血症风险的相关性。
Medicine (Baltimore). 2023 May 19;102(20):e33374. doi: 10.1097/MD.0000000000033374.
3
[Retarding progression of chronic kidney disease].
延缓慢性肾脏病进展
Inn Med (Heidelb). 2023 Mar;64(3):240-246. doi: 10.1007/s00108-023-01482-5. Epub 2023 Feb 1.
4
Altered Serum Uric Acid Levels in Kidney Disorders.肾脏疾病中血清尿酸水平的改变
Life (Basel). 2022 Nov 15;12(11):1891. doi: 10.3390/life12111891.
5
Peptide and its Complexes Protect Zebrafish and Mice From Hyperuricemia Through Promoting Kidney Excretion of Uric Acid and Inhibiting Liver Xanthine Oxidase Activity.肽及其复合物通过促进肾脏尿酸排泄和抑制肝脏黄嘌呤氧化酶活性来保护斑马鱼和小鼠免受高尿酸血症的影响。
Front Chem. 2022 Jun 28;10:924371. doi: 10.3389/fchem.2022.924371. eCollection 2022.
6
Effect Modification of Hyperuricemia, Cardiovascular Risk, and Age on Chronic Kidney Disease in China: A Cross-Sectional Study Based on the China Health and Nutrition Survey Cohort.高尿酸血症、心血管风险和年龄对中国慢性肾脏病的效应修正：一项基于中国健康与营养调查队列的横断面研究
Front Cardiovasc Med. 2022 Mar 7;9:853917. doi: 10.3389/fcvm.2022.853917. eCollection 2022.